Management of chronic neuropathic pain with single and compounded topical analgesics (Q50072130)

24 February 2018

title

Management of chronic neuropathic pain with single and compounded topical analgesics (English)

1 reference

24 February 2018

main subject

neuropathic pain

0 references

chronic neuropathic pain

0 references

pain management

0 references

author name string

Nebojsa Nick Knezevic

1 reference

24 February 2018

Tatiana Tverdohleb

1 reference

24 February 2018

Farid Nikibin

1 reference

24 February 2018

Ivana Knezevic

1 reference

24 February 2018

Kenneth D Candido

1 reference

24 February 2018

publication date

10 November 2017

1 reference

24 February 2018

published in

Pain management

1 reference

24 February 2018

volume

1 reference

24 February 2018

issue

1 reference

24 February 2018

page(s)

537-558

1 reference

24 February 2018

Advances in topical analgesics

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Epidemiology of neuropathic pain and its impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Neuropathic pain in the general population: a systematic review of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

What is localized neuropathic pain? A first proposal to characterize and define a widely used term.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Pharmacology and treatment of neuropathic pains

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Central sensitization: a generator of pain hypersensitivity by central neural plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Reorganization of dorsal root ganglion neurons following chronic sciatic nerve constriction injury: correlation with morphine and lidocaine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Peripheral input and its importance for central sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Mechanisms of sensory transduction in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Pharmacologic management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Skin Matters: A Review of Topical Treatments for Chronic Pain. Part Two: Treatments and Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical agents for the management of musculoskeletal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Practical considerations for optimal transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Stratum corneum defensive functions: an integrated view

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Skin permeation: the years of enlightenment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Relationship between dermato-physiological changes and hormonal status in pre-, peri-, and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Pluronic lecithin organogel as a topical drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Comparison of dermatopharmacokinetic vs. clinicial efficacy methods for bioequivalence assessment of miconazole nitrate vaginal cream, 2% in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

How do you feel? Interoception: the sense of the physiological condition of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

The cloned capsaicin receptor integrates multiple pain-producing stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

TRPV1 is activated by both acidic and basic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Sensory neuron-specific actions of capsaicin: mechanisms and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Postherpetic neuralgia: irritable nociceptors and deafferentation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

The neuroscience of placebo effects: connecting context, learning and health

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Effects of vehicle on the uptake and elimination kinetics of capsaicinoids in human skin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

The Capsaicin 8% Patch For Peripheral Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical analgesics in the management of acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

21 January 2018

Antidepressants and pain

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Severe postherpetic neuralgia and other neuropathic pain syndromes alleviated by topical gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA-sensitive potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

GABA(B) receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Phenytoin in topical formulations augments pain reduction of other topically applied analgesics in the treatment of trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical phenytoin for the treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Ketamine: an update on the first twenty-five years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical and peripheral ketamine as an analgesic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Intervention with spinal NMDA, adenosine, and NO systems for pain modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Clonidine: Clinical Pharmacology and Therapeutic Use in Pain Management

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Topical clonidine antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Relationship between plasma concentrations of clonidine and mean arterial pressure during an accidental clonidine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Toxicity from a clonidine suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Dermal exposure to a compounded pain cream resulting in severely elevated clonidine concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

Options in topical therapies in the management of patients with acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPMT-2017-0020

21 January 2018

Identifiers

DOI

10.2217/PMT-2017-0020

1 reference

24 February 2018

1 reference

24 February 2018